Instil Bio TIL Cash Flow Statement (2020-2026)

NASDAQ TIL
$7.40 -0.11 (-1.46%)
As of: Sep 10, 2026 · 3:17 PM EDT
Reported Financials

Instil Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Instil Bio reported cash from operations of -$4.64M and free cash flow of -$4.56M for the quarter ended Jun 2026, up 68.6% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-43.01M-55.35M-54.12M-58.99M-56.22M-53.84M-57.07M-18.66M-67.43M-12.93M-23.87M-14.21M-23.98M-13.47M-30.48M-23.98M-15.71M-10.38M-7.88M-6.53M
Share-based Compensation
8.74M8.90M7.49M8.32M7.98M6.64M4.53M4.41M4.67M4.55M4.51M4.17M4.07M4.50M3.50M1.82M1.77M1.61M0.98M1.23M
Gains from Investment Securities
0.17M0.16M-0.35M-0.62M0.27M-2.19M-0.24M0.15M0.04M-3.34M0.10M0.10M-2.70M-1.41M-0.95M
Asset Writedowns and Impairment
1.74M13.10M0.92M41.50M2.53M0.10M0.04M16.57M0.03M0.18M
Cash from Restructuring
5.43M-0.21M-1.67M-0.37M-0.05M0.78M-0.85M
Cash from Operations
-29.39M-42.79M-55.05M-47.26M-40.88M-36.98M-34.66M-19.56M-14.43M-13.38M-14.39M-10.61M-20.13M-10.56M-4.20M-14.79M-10.56M-7.08M-1.34M-4.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.01M0.01M0.90M-0.07M0.47M0.47M0.27M-0.16M0.49M0.03M
Depreciation & Amortization (CF)Depreciation & Amortization
0.76M0.89M0.90M1.05M1.94M2.10M1.78M0.99M0.95M1.04M0.99M0.97M0.90M0.74M0.50M0.01M0.01M0.01M0.01M0.25M
Change in Working Capital
Change in Account Payables
1.75M0.11M-3.20M4.11M-0.23M-2.49M-0.98M0.75M-0.42M-0.48M0.02M-0.01M-0.04M-0.52M-0.38M0.24M0.40M-0.15M0.02M
Change in Accured Expenses
3.35M7.56M-2.93M-0.46M3.21M-14.24M-1.48M-2.56M-1.26M-2.48M0.86M-1.04M-0.17M-1.54M-1.01M-2.16M1.59M-0.77M0.05M-1.63M
Other Working Capital Changes
0.10M2.17M2.83M1.78M-2.44M-0.54M0.77M0.73M-2.70M-0.21M-1.34M-1.17M5.04M-3.92M-6.48M0.65M0.90M-1.18M-1.53M0.16M
Investing Activities
Capital Expenditures
21.75M18.46M20.23M26.14M25.20M13.01M9.50M5.95M5.16M0.06M0.20M0.70M2.21M1.25M-0.08M-0.17M-0.09M-0.08M-0.08M-0.08M
Sales of Property, Plant and Equipment
1.56M0.54M0.01M0.32M0.41M0.01M0.01M0.01M
Acquisitions
Change in Acquisitions & Divestments
205.00M486.00M350.50M225.50M135.00M154.35M105.00M113.80M79.50M63.40M59.90M51.80M47.00M39.40M47.40M38.30M25.00M25.20M22.00M22.80M
Cash from Investing Activities
-516.73M59.96M77.87M-21.50M25.37M32.80M14.53M10.33M2.32M13.95M9.24M11.92M19.81M13.00M9.61M-0.40M8.45M7.82M-0.32M5.29M
Financing Activities
Other financing activities
0.34M0.56M0.27M0.38M0.16M0.21M0.40M0.07M0.38M
Debt Issuance and Repayment
Long-Term Debt Issuances
50.06M14.45M5.83M4.47M4.20M85.60M
Change in Capital Stock
Net Equity Issued and Repurchased
Misc.
Cash from Financing Activities
0.12M0.20M0.34M50.62M14.72M6.20M4.47M4.20M-0.59M0.16M1.60M0.23M6.68M0.38M
Exchange Rate Effect
0.13M-0.18M0.73M-0.87M-0.56M0.07M-0.02M-0.07M-0.09M-0.02M-0.06M-0.01M0.04M-0.07M0.04M0.02M-0.03M-0.02M-0.01M0.00M
Change in Cash
-546.01M17.37M23.15M-18.14M-0.78M2.03M-15.67M-5.03M-12.69M0.57M-5.15M1.30M-0.16M4.04M5.65M-8.51M-1.73M0.74M-1.65M0.65M
Free Cash Flow
-51.14M-61.25M-75.29M-73.40M-66.08M-49.99M-44.16M-25.51M-19.58M-13.44M-14.59M-11.32M-22.35M-11.81M-4.12M-14.62M-10.46M-7.00M-1.26M-4.56M
Net Cash Flow
-546.01M17.37M23.15M-18.14M-0.78M2.03M-15.67M-5.03M-12.69M0.57M-5.15M1.30M-0.16M4.04M5.65M-8.51M-1.73M0.74M-1.65M0.65M